Efficacy and safety of abrocitinib for moderate-to-severe atopic dermatitis in adolescents and adults: Meta-analysis

Objective: This study aims to investigate the safety and efficacy of abrocitinib in treating moderate-to-severe AD in adolescents and adults. Methods: Pubmed, Cochrane, Embase, and Web of science data base were searched from inception to 9 August 2022. All randomized controlled trials (RCTs) evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ling, Yu, Jiajun, Chen, Baoqing, Guo, Ying, Yang, Yufeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192817/
https://www.ncbi.nlm.nih.gov/pubmed/37214438
http://dx.doi.org/10.3389/fphar.2023.1154949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192817/
https://www.ncbi.nlm.nih.gov/pubmed/37214438
http://dx.doi.org/10.3389/fphar.2023.1154949

Ejemplares similares